Business, energy, technology, markets and global industry news from Business News Today

Merck

PharmaDeviceNews Merck
A representative image of advanced single-cell analysis and AI-driven drug discovery workflows, reflecting Illumina’s Billion Cell Atlas initiative with AstraZeneca, Merck, and Eli Lilly to accelerate next-generation precision medicine.
Medical Devices & Diagnostics

Illumina’s Billion Cell Atlas marks inflection point for AI-enabled drug discovery in 2026

Illumina, Inc. has launched the Billion Cell Atlas, a large-scale genetic perturbation dataset designed to serve as foundational infrastructure for artificial intelligence-enabled drug discovery. Announced alongside strategic collaborations with AstraZeneca, Merck, and Eli Lilly and Company, the platform leverages CRISPR-based genome editing and single-cell RNA sequencing across more than 200 disease-relevant cell lines. This marks

Read More
Pharma & Biotech

Merck’s WINREVAIR clears major EU hurdle with CHMP backing for WHO FC IV patients

Merck has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency recommending an expanded indication for WINREVAIR (sotatercept) in combination with other therapies for the treatment of pulmonary arterial hypertension (PAH) in adults across WHO Functional Classes II, III, and IV. The update follows pivotal

Read More